CRISPR Skin Grafts Instead of Insulin Injections
September 12, 2017 | Terry Sharrer
Researchers at the University of Chicago have used CRISPR gene editing to establish proof of concept in lab animals that skin cells can be reprogrammed to produce glucagon-like peptide 1 which lowers blood sugar levels and suppresses appetite. As this piece concludes, “these results highlight the clinical potential of developing long-lasting, safe, and versatile gene therapy approaches based on engineering epidermal progenitor cells.” MORE
Image Credit: Science Life, University of Chicago, Medicine and Biological Sciences